| Members |
targetComponentId |
| Estimated intravenous intake of fat and oil in 24 hours |
Estimated quantity of intake of fat and oil via intravenous fluids in 24 hours (observable entity) |
| Estimated oil servings in 24 hours |
The approximate amount of food oil foods consumed per day, where a serving is the amount of that food customarily considered a serving. |
| Estimated parenteral intake of carbohydrate in 24 hours |
The approximate intake of carbohydrate in grams per day derived from parenteral nutrition infusion. |
| Estimated parenteral intake of fat and oil in 24 hours |
The approximate intake of fat and oil in grams in one day derived from parenteral nutrition infusion. |
| Estimated plant fiber requirement in 24 hours |
Estimated quantity of total plant fiber needed for nutritional adequacy in one day. |
| Estimated protein and protein derivative requirement in 24 hours |
Estimated quantity of total protein needed for nutritional adequacy in one day. |
| Estimated protein and protein derivative requirement per kilogram body weight in 24 hours |
The approximate quantity of total protein needed for nutritional adequacy for each kilogram of body weight in one day. |
| Estimator(s) &/or valuer(s) &/or assessor(s) [& (insurance)] |
Estimator |
| Estimator(s) &/or valuer(s) &/or assessor(s) [& (insurance)] |
Estimators/valuers/assessors |
| Estimator(s) &/or valuer(s) &/or assessor(s) [& (insurance)] |
Estimators/valuers/assessors |
| Estimator(s) &/or valuer(s) &/or assessor(s) [& (insurance)] |
Estimator |
| Estimator(s) &/or valuer(s) &/or assessor(s) [& (insurance)] |
Insurance assessor |
| Estimator(s) &/or valuer(s) &/or assessor(s) [& (insurance)] |
Insurance assessor |
| Estimator(s) &/or valuer(s) &/or assessor(s) [& (insurance)] |
Valuer |
| Estimator(s) &/or valuer(s) &/or assessor(s) [& (insurance)] |
Valuer |
| estradiol 1 mg + estradiol 1 mg + norgestimat 0,09 mg tablet |
Product containing ethinylestradiol and norgestimate (medicinal product) |
| Estradiol 1.25g/dose gel |
Estradiol-containing product in cutaneous dose form |
| Estradiol 1.25g/dose gel |
Estradiol-containing product in cutaneous dose form |
| estradiol 100 µg plaster |
Product containing precisely estradiol 4.167 microgram/1 hour prolonged-release transdermal patch (clinical drug) |
| estradiol 25 µg plaster |
Estradiol 1.042 microgram/hour prolonged-release transdermal patch |
| estradiol 2 mg |
Estradiol 2 mg oral tablet |
| estradiol 37,5 µg plaster |
Estradiol 1.563 microgram/hour prolonged-release transdermal patch |
| estradiol 40 µg plaster |
Product containing precisely estradiol 1.667 microgram/1 hour prolonged-release transdermal patch (clinical drug) |
| estradiol 50 µg plaster |
Product containing precisely estradiol 2.083 microgram/1 hour prolonged-release transdermal patch (clinical drug) |
| estradiol 75 µg plaster |
Estradiol 3.125 microgram/hour prolonged-release transdermal patch |
| estradiol 80 µg plaster |
Product containing precisely estradiol 3.333 microgram/1 hour prolonged-release transdermal patch (clinical drug) |
| Estrogen |
Estrogen receptor agonist |
| estrogen |
Substance with estrogen receptor agonist mechanism of action (substance) |
| bivirkning af østrogen- og progestogenpræparat |
Adverse reaction to estrogen and/or progesterone (disorder) |
| ER relateret til celleoverflade |
ER related to cell surface |
| etanercept 25 mg pulver og solvent til injektionsvæske, opløsning, hætteglas |
Product containing precisely etanercept 25 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
| Etanercept 25mg/vial powder |
Product containing precisely etanercept 25 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
| etanercept 50 mg pulver og solvent til injektionsvæske, opløsning, hætteglas |
Product containing precisely etanercept 50 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
| Etchant |
Etchant (substance) |
| Etchant |
Use of etchant (attribute) |
| Etcher &/or engraver |
Engraver (occupation) |
| Etcher &/or engraver |
Etcher/engraver |
| Etcher &/or engraver |
Engraver (occupation) |
| Etcher &/or engraver |
Etcher/engraver |
| Etcher &/or engraver |
Etcher |
| Etcher &/or engraver |
Etcher |
| ethanolaminoleat 5 % injektionsvæske, opløsning, 2 ml ampul |
Product containing precisely ethanolamine oleate 50 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| ethanolaminoleat 5 % injektionsvæske, opløsning, 5 ml ampul |
Product containing precisely ethanolamine oleate 50 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| ether |
Substance with ether structure |
| ether |
Diethyl ether (substance) |
| overdosis af ether |
Diethyl ether overdose |
| overdosis af ether, uvist med hvilken hensigt |
Diethyl ether overdose |
| flygtigt væskeformigt ether |
Ether structure-containing product |
| Ethmoid sinusotomy |
Exploration of ethmoid sinus |
| Ethmoid sinusotomy |
Ethmoidotomy (procedure) |
| Ethmoidal vein and tributaries |
Entire ethmoidal vein |
| Ethmoidal vein and tributaries |
Structure of ethmoidal vein |
| Ethnic group finding |
Ethnic group finding (finding) |
| Ethnic group finding |
Ethnic background (finding) |
| Ethnic groups (census) |
Ethnic group (ethnic group) |
| Ethnic groups (census) NOS |
Ethnic group (ethnic group) |
| Ethnic groups (census) NOS |
Ethnic group (ethnic group) |
| Ethosuccimide level &/or serum) |
Serum ethosuximide measurement |
| Ethosuccimide level &/or serum) |
Serum ethosuximide measurement |
| Ethylamino derivative of phenothiazine |
Phenothiazine derivative (substance) |
| Ethylene glycol poisoning |
Antifreeze poisoning (disorder) |
| Ethylene glycol poisoning |
Ethylene glycol poisoning (disorder) |
| etodolac 600 mg tablet med modificeret udløsning |
Product containing precisely etodolac 600 milligram/1 each prolonged-release oral tablet (clinical drug) |
| Etoricoxib 120mg tablet |
Etoricoxib 120 mg oral tablet |
| Etoricoxib 60mg tablet |
Etoricoxib 60 mg oral tablet |
| Etoricoxib 90mg tablet |
Etoricoxib 90 mg oral tablet |
| Eubacterium-art |
Eubacterium |
| Eucalyptus pollen allergen |
Eucalyptus pollen (substance) |
| stof til lappeprøve for eucerin |
Vehicle and emulsifier patch test product (product) |
| stof til lappeprøve for Eucerin |
Vehicle and emulsifier patch test substance |
| Eucopepod |
Family Lernaeidae (organism) |
| European avocet |
Recurvirostra avosetta (organism) |
| European long-eared owl |
Asio otus (organism) |
| European oyster-catcher |
Haematopus ostralegus (organism) |
| European song thrush |
Turdus iliacus (organism) |
| European song thrush |
Turdus philomelos (organism) |
| Euroscore for angina pectoris |
European system for cardiac operative risk evaluation (assessment scale) |
| Euroscore for angina |
European system for cardiac operative risk evaluation (assessment scale) |
| Euroscore for angina |
European system for cardiac operative risk evaluation (assessment scale) |
| Eustachian catheter, reusable |
Eustachian catheter (physical object) |
| Eustachian catheter, single-use |
Eustachian catheter (physical object) |
| Eustachian tube: [salpingitis] or [catarrh] |
Catarrh - eustachian |
| Eustachian tube: [salpingitis] or [catarrh] |
Eustachian tube salpingitis (disorder) |
| Eustrongylides species |
Eustrongylides |
| Evacuation - action |
Evacuation - action |
| Evacuation gastrointestinal contents (& gastric drainage) |
Evacuation of GIT contents |
| Evacuation gastrointestinal contents (& stomach) |
Evacuation of GIT contents |
| Evacuation of perianal haematoma |
Evacuation of perianal hematoma |
| Evacuation of perianal haematoma |
Thrombosed hemorrhoid incised (situation) |
| Evaluation and management - action |
Evaluation - action |
| Evaluation and management - action |
Action |
| Evans' operation |
Evans osteotomy of calcaneus |
| Evoked |
Evoked (qualifier value) |
| Evoked |
Provoked by (attribute) |
| Evoked potential, function (observable entity) |
Evoked potentials monitoring |
| Evoked potential, function (observable entity) |
Evoked potential, function (observable entity) |
| Evoked potentials |
Evoked potential, function (observable entity) |
| Evoked potentials |
Evoked potentials monitoring |
| Ewingella-art |
Ewingella |
| Forhenværende ryger med stort forbrug (20-39 eller tilsvarende om dagen) |
Ex-heavy cigarette smoker (20-39/day) |
| Forhenværende ryger med let forbrug (1-9 cigaretter eller tilsvarende om dagen) |
Ex-light cigarette smoker (1-9/day) |
FHIR